Istituto Cantonale di Patologia

Wild-Type <i>BRAF</i> Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer

Federica Di Nicolantonio, Miriam Martini, Francesca Molinari et al. · Journal of Clinical Oncology · 2008 · 1.6K citations · Full text

Kras Mutations, Gastrointestinal Oncology, Medicine +13

<i>PIK3CA</i> Mutations in Colorectal Cancer Are Associated with Clinical Resistance to EGFR-Targeted Monoclonal Antibodies

Andrea Sartore‐Bianchi, Miriam Martini, Francesca Molinari et al. · Cancer Research · 2009 · 735 citations

Side Kras, Pathology, Tumor Biology +17

PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients

Milo Frattini, Piercarlo Saletti, Elena Romagnani et al. · British Journal of Cancer · 2007 · 536 citations · Full text

Role of the pineal gland in immunity

Georges J. M. Maestroni, Ario Conti, Walter Pierpaoli · Journal of Neuroimmunology · 1986 · 409 citations

Inflammation, Humoral Response, Immunology +4

Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type

A. Conconi · Blood · 2003 · 400 citations · Full text